Tag Archives: Chronic Obstructive Pulmonary Disease inhaler

In a major clinical breakthrough for respiratory healthcare in India, pharmaceutical major Lupin Limited has launched Formoflo-G MDI, heralded as the world’s first fixed-dose triple-combination metered-dose inhaler designed for Chronic Obstructive Pulmonary Disease (COPD). Approved by the Drugs Controller General of India (DCGI), this novel therapeutic device integrates three proven …

Read More »